We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

MaxCyte

Apeiron licence broadens the MaxCyte opportunity

Lighthouse | 08 July 2020

BerGenBio

AXL-erating towards new opportunities

Outlook | 29 June 2020

Futura Medical

AGM statement confirms MED3000 filings on track

Update | 29 June 2020

Bonesupport

Swings and roundabouts

Update | 29 June 2020

Hutchison China MediTech

General Atlantic invests $100m at 10% premium

Lighthouse | 25 June 2020

Hutchison China MediTech

ASCO 2020: savo and suru data drives regulatory progress

Update | 04 June 2020

Mereo BioPharma

Private placement raises $70m (£56m)

Lighthouse | 04 June 2020

Nexstim

€2.3m rights issue is 273% subscribed

Update | 02 June 2020

Futura Medical

Nearing the critical point in Erectile Dysfunction

Outlook | 02 June 2020

MaxCyte

ASCO poster shows encouraging data for MCY-M11

Lighthouse | 02 June 2020
196 results found.